CRENESSITY
Live / Registered — Registered (as of 28 Oct 2025)
What this means for you
Registered since 28 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99975033
- Registration number
- 8005099
- Mark type
- Design + words
- Filed
- 29 Jan 2025
- Published for opposition
- 09 Sept 2025
- Registered
- 28 Oct 2025
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 28 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 09 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Sept 2025 — PUBLISHED FOR OPPOSITION
- 03 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Aug 2025 — USE AMENDMENT ACCEPTED
- 01 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Jul 2025 — AMENDMENT TO USE PROCESSING COMPLETE
- 10 Jul 2025 — USE AMENDMENT FILED
- 23 Jul 2025 — DIVISIONAL PROCESSING COMPLETE
- 10 Jul 2025 — DIVISIONAL REQUEST RECEIVED
- 21 Jul 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL